ThailandMarket Entry & Growth in Thailand
Thailand's USD 27 billion healthcare market and its role as Southeast Asia's medical hub make it a priority destination for life-sciences brands. Taevas delivers end-to-end FDA Thailand navigation, distributor access, and commercial launch support so you
Four Industries. One Thailand Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your Thailand market entry.
Medical Devices & Equipment
Thai Food and Drug Administration, Medical Device Control Division
Thailand's medical device market exceeds USD 2 billion annually and is growing rapidly, driven by medical tourism, public hospital upgrades, and an ageing population. The Thai FDA classifies devices into three risk classes and requires product registration and import licences before any commercial sale. Taevas manages the full regulatory submission lifecycle, from classification advice to post-market surveillance, ensuring your device reaches Thai clinicians without delay.
Regulatory Pathways
Device Classification and Listing
Class 1 low-risk devices require a notification filing with Thai FDA, while Class 2 and Class 3 devices require full product registration with technical dossiers. Correct classification at the outset prevents costly resubmissions and delays.
Product Registration (Class 2 and 3)
Class 2 and Class 3 devices must submit a complete technical dossier including clinical evidence, labelling, and manufacturing quality documentation to Thai FDA. Review timelines range from 6 to 18 months depending on device risk and dossier completeness.
Import Licence and Customs Clearance
All registered medical devices require a valid import licence issued by Thai FDA prior to each shipment entering Thailand. Taevas coordinates HS code alignment, customs documentation, and liaison with the Department of Foreign Trade.
Post-Market Surveillance and Renewal
Registered medical devices in Thailand must undergo periodic licence renewal and adverse event reporting in compliance with Thai FDA post-market requirements. Taevas provides ongoing pharmacovigilance-equivalent monitoring and renewal management.
Our Services for Medical Devices in Thailand
Why Global Brands Choose Taevas for Thailand
Taevas combines deep Thai FDA regulatory expertise with on-the-ground commercial networks, giving life-sciences companies a single accountable partner from first submission to sustained market growth in Thailand.
Thai FDA Regulatory Mastery
Our Bangkok-based regulatory team has navigated Thai FDA submissions across medical devices, pharmaceuticals, cosmetics, and food supplements, delivering approvals on time and in full. We know the nuances of Thai FDA processes that generic consultants miss.
ASEAN Market Perspective
Thailand sits at the heart of ASEAN, and our regional footprint means we can align your Thai regulatory strategy with harmonised ASEAN frameworks, enabling faster multi-market expansion across Southeast Asia from a single engagement.
Faster Time to Market
Our pre-submission review process and established Thai FDA relationships reduce dossier rejection rates and compress typical registration timelines, getting your product to Thai healthcare professionals and consumers ahead of competitors.
Established Distributor Network
Taevas maintains active relationships with vetted distributors across public hospitals, private hospital groups, pharmacy chains, modern trade retailers, and e-commerce platforms throughout Thailand's 77 provinces.
KOL and Clinical Networks
We have cultivated relationships with key opinion leaders across Thai medical specialities and pharmacy academia, enabling credible clinical endorsement programmes that accelerate product adoption in Thailand's healthcare community.
Proven Commercial Track Record
From first regulatory submission to commercial launch and sustained revenue growth, Taevas has supported numerous international life-sciences brands in building profitable, compliant businesses in the Thai market.
Ready to Enter the Thailand Market?
Speak with a Taevas Thailand specialist today to map your regulatory pathway, assess your commercial opportunity, and build a launch plan that moves from submission to revenue with confidence.